Brind.

Altimmune initiated the RESTORE Phase 2 trial.

1 report, 0 independent Updated Jul 9

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Altimmune, Inc.Restore

Keep exploring

The entities involved

Altimmune, Inc.
American biopharmaceutical company
- X4 Pharmaceuticals and Altimmune, Inc. are small-cap healthcare companies trading on the Nasdaq stock exchange.Thu 14:20
Restore
nonprofit organization in London, United Kingdom

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 9Unknown outlet